Overview

Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) drug (alfimeprase).
Phase:
Phase 2
Details
Lead Sponsor:
ARCA Biopharma, Inc.
Collaborator:
Health Decisions